Novavax, Inc.
Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2014 Financial Results on February 26, 2015
DGAP-News: Novavax, Inc. 2015-02-19 / 22:05 --------------------------------------------------------------------- GAITHERSBURG, Md., 2015-02-19 22:05 CET (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced it will report its fourth quarter and full year 2014 financial and operating results after the close of U.S. financial markets on Thursday, February 26, 2015. In addition, management will host a conference call to discuss the quarterly and year-end financial results and provide an update on corporate activities. Conference call details are as follows: Date: February 26, 2015 Time: 4:30 pm US Eastern Time Dial-in number: (877) 212-6076 (Domestic) or (707) 287-9331 (International) Via web: www.novavax.com Conference call replay: Dates: Starting at 6:31 pm ET on February 26, 2015 until midnight March 5, 2015 Dial-in (855) 859-2056 (Domestic) or (404) 537-3406 (International) number: Passcode: 89629680 Via web: www.novavax.com, 'Investor Info'/'Events' About Novavax Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and Matrix-M(TM) adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. Additional information about Novavax is available on the company's website, novavax.com. CONTACT: Barclay A. Phillips SVP, Chief Financial Officer and Treasurer Andrea N. Flynn, Ph.D. Senior Manager, Investor Relations 240-268-2000 ir@novavax.com Novavax, Inc. David Schull or Todd Davenport, Ph.D. Russo Partners, LLC 212-845-4271 david.schull@russopartnersllc.com todd.davenport@russopartnersllc.com News Source: NASDAQ OMX --------------------------------------------------------------------- 2015-02-19 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Novavax, Inc. United States ISIN: US6700021040 End of News DGAP News-Service --------------------------------------------------------------------- 325325 2015-02-19
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden